February 23, 2026 01:00 ET | Source: argenx SE February 23, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX),…
February 22, 2026 16:00 ET | Source: Dyne Therapeutics, Inc. - Late-breaking poster to feature new positive cardiopulmonary function results…
PALO ALTO, Calif. and MULGRAVE, Australia, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Gyder Surgical, a MedTech company specializing in intuitive, non-invasive…
Press ReleaseVELIZY-VILLACOUBLAY, France — February 21, 2026 Dassault Systèmes’ CEO Pascal Daloz becomes also Chairman of the Board of Directors…
Amsterdam, Netherlands, Feb. 21, 2026 (GLOBE NEWSWIRE) -- February 20, 2026 – Weaviate, the leading open-source AI database, today announced…
LOS ANGELES, CA, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Seedance2ai.online today announced the public launch of its video creation platform…
West Midlands Mayor Leads Strategic UK Delegation to Translate Sporting Ambition into Long-Term Economic PartnershipsAHMEDABAD, India, Feb. 21, 2026 /PRNewswire/…
Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions,…
February 20, 2026 15:10 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…
Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…